CIK 0001635088 · Large accelerated filer
Roivant Sciences Ltd.
Sign in to watch- Ticker
- ROIV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- Bermuda
- Entity type
- operating
- EIN
- 981173944
- Phone
- 441-295-5950
- Business address
- 7TH FLOOR, 50 BROADWAY, LONDON, United Kingdom, SW1H 0DB
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $85,719,562
- in 13 filings, $45.5M under 10b5-1 plans
Net −$85,719,562. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-20 | Gline Matthew CEO | Shares withheld for taxes | −11,623 | $11.15 | $130K | 17,327,546 |
| 2024-12-30 | Venker Eric President & COO | Option exercise | +250,000 | $3.85 | $963K | 918,680 |
| 2024-12-30 | Venker Eric President & COO | Sale | −177,704 | $11.54 | $2.1M | 740,976 |
| 2024-12-30 | Venker Eric President & COO | Option exercise · Stock Option (Right to Buy) | −250,000 | 11,726,234 | ||
| 2024-12-28 | Pulik Richard CFO | Shares withheld for taxes | −1,896 | $11.80 | $22K | 272,576 |
| 2024-12-27 | Venker Eric President & COO | Option exercise | +250,000 | $3.85 | $963K | 845,580 |
| 2024-12-27 | Venker Eric President & COO | Sale | −176,900 | $11.82 | $2.1M | 668,680 |
| 2024-12-27 | Venker Eric President & COO | Option exercise · Stock Option (Right to Buy) | −250,000 | 11,976,234 | ||
| 2024-12-26 | Sukhatme Mayukh Pres&Chief Investment Officer | Option exercise | +689,495 | $3.85 | $2.7M | 19,526,042 |
| 2024-12-26 | Sukhatme Mayukh Pres&Chief Investment Officer | Sale | −689,495 | $12.01 | $8.3M | 18,836,547 |
| 2024-12-26 | Sukhatme Mayukh Pres&Chief Investment Officer | Option exercise · Stock Option (Right to Buy) | −689,495 | 15,224,363 | ||
| 2024-12-24 | Sukhatme Mayukh Pres&Chief Investment Officer | Option exercise | +185,946 | $3.85 | $716K | 19,022,493 |
| 2024-12-24 | Sukhatme Mayukh Pres&Chief Investment Officer | Sale | −185,946 | $12.00 | $2.2M | 18,836,547 |
| 2024-12-24 | Sukhatme Mayukh Pres&Chief Investment Officer | Option exercise · Stock Option (Right to Buy) | −185,946 | 15,913,858 | ||
| 2024-12-23 | Sukhatme Mayukh Pres&Chief Investment Officer | Option exercise | +10,796 | $3.85 | $42K | 18,847,343 |
| 2024-12-23 | Sukhatme Mayukh Pres&Chief Investment Officer | Sale | −10,796 | $12.00 | $130K | 18,836,547 |
| 2024-12-23 | Sukhatme Mayukh Pres&Chief Investment Officer | Option exercise · Stock Option (Right to Buy) | −10,796 | 16,099,804 | ||
| 2024-12-20 | Pulik Richard CFO | Shares withheld for taxes | −2,129 | $11.57 | $25K | 274,472 |
| 2024-12-20 | Kumar Rakhi Chief Accounting Officer | Shares withheld for taxes | −3,087 | $11.57 | $36K | 204,321 |
| 2024-12-20 | Venker Eric President & COO | Shares withheld for taxes 10b5-1 | −10,945 | $11.57 | $127K | 595,580 |
Page 26 of 29 · 570 trades